Maker of weight-loss drugs to ask Trump to pause price negotiations: Report
Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price negotiations that were put in place by the Biden administration's Inflation Reduction Act (IRA). "They need to fix [the IRA]," Eli Lilly CEO Dave Ricks told Bloomberg at the JPMorgan Healthcare Conference in San Francisco.
This year’s JPMorgan health-care conference took place a month after UnitedHealthcare CEO Brian Thompson was fatally shot in ...
10don MSN
President-elect Donald Trump’s threat to slap Denmark with tariffs to force its hand in giving up Greenland could lead to ...
President-elect Donald Trump's viral photo with a Diet Coke bottle highlights its popularity for weight loss. However, this ...
Although ending the program won’t be easy since it requires authorization from Congress, recent moves by President-elect Donald Trump’s allies ... so making weight loss drugs more affordable ...
President-elect Donald Trump 's threat to "tariff Denmark at a very high level" if it refuses to give up Greenland could ...
NEW YORK (Reuters) - As investors seek assets that will shine under a Donald Trump presidency ... The Russell 2000 held a 37% weight with those two sectors as of the end of 2024, compared to ...
President-elect Donald Trump’s quest to buy Greenland from Denmark could make Ozempic and Wegovy, the weight-loss and diabetes drugs exploding in popularity, even more expensive for Americans.
Although ending the program won’t be easy since it requires authorization from Congress, recent moves by President-elect Donald Trump’s allies may not bode well for its future, said Juliette ...
President-elect Donald Trump faces deep skepticism that his administration's policies will make health care more affordable, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback